The page is the record's research on the issuer — no analyst, no rating, no view. # Aquestive Therapeutics, Inc. (NASDAQ: AQST) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Aquestive Therapeutics, Inc., listed on NASDAQ under ticker AQST, with ISIN US03843E1047. The LEI is not on the record, as there is no GLEIF record with the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 92 filings in the window from 2025-11-08 to 2026-11-08, across 56 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-11-05, three days before the record date, and is of type corporate news. On NASDAQ the median cadence gap is 6.0 days, the median filings are 52, and the median latency is 5.0 days across 4359 issuers. On the sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings are 63.0, and the median latency is 4.0 days across 526 issuers. ## Auditor The auditor of record is KPMG LLP, located in Short Hills, New Jersey. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001398733.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/AQST (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1398733/000139873326000018/aqst-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/AQST (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/AQST · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp